Metabolic Heterogeneity in Polycystic Ovary Syndrome Is Determined by Obesity: Plasma Metabolomic Approach Using GC-MS

scientific article published on 16 March 2012

Metabolic Heterogeneity in Polycystic Ovary Syndrome Is Determined by Obesity: Plasma Metabolomic Approach Using GC-MS is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1373/CLINCHEM.2011.176396
P698PubMed publication ID22427353

P50authorMiguel A LasunciónQ40744743
Manuel Luque-RamírezQ43185417
Héctor Escobar MorrealeQ43185421
Maria VinaixaQ52278264
Xavier CorreigQ53340599
Sara SaminoQ56084646
María InsenserQ81499543
P2093author name stringM. A. Lasuncion
M. Insenser
M. Luque-Ramirez
P4510describes a project that usesgas chromatography-mass spectrometryQ873009
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectobesityQ12174
polycystic ovary syndromeQ500816
polycystic ovaryQ5547896
heterogeneityQ928498
P304page(s)999-1009
P577publication date2012-03-16
P1433published inClinical ChemistryQ849687
P1476titleMetabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS
P478volume58

Reverse relations

cites work (P2860)
Q87398077Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients
Q37640691Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population.
Q38776405Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome
Q26739194Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?
Q33593356Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep
Q33591287Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women
Q37512804Electrospray Quadrupole Travelling Wave Ion Mobility Time-of-Flight Mass Spectrometry for the Detection of Plasma Metabolome Changes Caused by Xanthohumol in Obese Zucker (fa/fa) Rats
Q47152469Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients
Q53362637Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition.
Q37501409Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome.
Q34496769Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis
Q64058719Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
Q64094829Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS
Q43852376Metformin in women with PCOS, pros
Q26752564Poly Cystic Ovarian Syndrome: An Updated Overview
Q38258968Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity
Q52345007Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
Q36560506Targeted metabolomics finds its mark in diabetes research
Q36943683Targets to treat metabolic syndrome in polycystic ovary syndrome

Search more.